Vesicular systems in ocular drug delivery: an overview

被引:315
作者
Kaur, IP [1 ]
Garg, A [1 ]
Singla, AK [1 ]
Aggarwal, D [1 ]
机构
[1] Panjab Univ, Inst Pharmaceut Sci, Chandigarh 160014, India
关键词
niosomes; liposomes; vesicular drug delivery; ophthalmics;
D O I
10.1016/j.ijpharm.2003.09.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main aim of pharmacotherapeutics is the attainment of effective drug concentration at the intended site of action for a sufficient period of time to elicit a response. Poor bioavailability of drugs from ocular dosage form is mainly due to the tear production, non-productive absorption, transient residence time, and impermeability of corneal epithelium. Though the topical and localized application are still an acceptable and preferred way to achieve therapeutic level of drugs used to treat ocular disorders but the primitive ophthalmic solution, suspension, and ointment dosage form are no longer sufficient to combat various ocular diseases. This article reviews the constraints with conventional ocular therapy and explores various novel approaches, in general, to improve ocular bioavailability of the drugs, advantages of vesicular approach over these and the future challenges to render the vesicular system more effective. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 99 条
[71]  
Oommen Elsie, 1999, Indian Journal of Pharmacology, V31, P279
[72]   BIOADHESIVE POLYMERS AS PLATFORMS FOR ORAL-CONTROLLED DRUG DELIVERY - METHOD TO STUDY BIOADHESION [J].
PARK, K ;
ROBINSON, JR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 19 (02) :107-127
[73]  
PLEYER U, 1993, INVEST OPHTH VIS SCI, V34, P2737
[74]   CLINICAL USES OF COLLAGEN SHIELDS [J].
POLAND, DE ;
KAUFMAN, HE .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1988, 14 (05) :489-491
[75]  
ROBINSON JR, 1990, BIOADHESION POSSIBIL, P109
[76]  
Saettone MF, 1996, STP PHARMA SCI, V6, P94
[77]   OCULAR INSERTS FOR TOPICAL DELIVERY [J].
SAETTONE, MF ;
SALMINEN, L .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (01) :95-106
[78]   PENETRATION OF BETA-BLOCKERS THROUGH OCULAR MEMBRANES IN ALBINO RABBITS [J].
SASAKI, H ;
IGARASHI, Y ;
NAGANO, T ;
YAMAMURA, K ;
NISHIDA, K ;
NAKAMURA, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (01) :17-21
[79]  
SCHAEFFER HE, 1982, INVEST OPHTH VIS SCI, V23, P530
[80]  
SCHAEFFER HE, 1982, INVEST OPHTH VIS SCI, V22, P220